{
  "paper_metadata": {
    "pmid": "29339979",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for BRCA2, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.2808_2811del",
      "protein_notation": "p.Ala938Profs*8",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 368,
        "demographics": "Norwegian",
        "phenotype": "Breast and ovarian cancer risk"
      },
      "penetrance_data": {
        "total_carriers_observed": 368,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "This variant leads to a frameshift and is classified as pathogenic.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "Strong evidence based on classification as pathogenic.",
      "source_location": "Table 3, Row 3",
      "additional_notes": "This variant is noted as a Norwegian founder mutation.",
      "key_quotes": [
        "c.2808_2811del p.Ala938Profs*8 is a Norwegian founder mutation."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.3847_3848del",
      "protein_notation": "p.Val1283Lysfs*2",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 214,
        "demographics": "Norwegian, Iranian",
        "phenotype": "Breast and ovarian cancer risk"
      },
      "penetrance_data": {
        "total_carriers_observed": 214,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "This variant leads to a frameshift and is classified as pathogenic.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "Strong evidence based on classification as pathogenic.",
      "source_location": "Table 3, Row 4",
      "additional_notes": "This variant is noted as a Norwegian and Iranian founder mutation.",
      "key_quotes": [
        "c.3847_3848del p.Val1283Lysfs*2 is a Norwegian, Iranian founder mutation."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 3",
      "table_caption": "BRCA2 variants",
      "variants_extracted": 2
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data for BRCA2 variants were extracted successfully."
  }
}